Parnax Lab Ltd.
| BSE: 506128 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE383L01019 |
| BSE 00:00 | 03 Aug | 17.00 |
0.50 (3.03%) |
OPEN
17.20 |
HIGH
17.20 |
LOW
17.00 |
| NSE 05:30 | 01 Jan | Parnax Lab Ltd |
| OPEN | 17.20 |
| PREVIOUS CLOSE | 16.50 |
| VOLUME | 702 |
| 52-Week high | 31.00 |
| 52-Week low | 11.65 |
| P/E | |
| Mkt Cap.(Rs cr) | 14 |
| Buy Price | 16.10 |
| Buy Qty | 15.00 |
| Sell Price | 17.15 |
| Sell Qty | 487.00 |
Parnax Lab Ltd. (PARNAXLAB) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 519.80 | -2.25 | 540.75 | 315.20 | 124715.61 |
| Dr Reddy's Labs | 4524.10 | 0.05 | 4666.70 | 2352.00 | 75208.64 |
| Divi's Lab. | 2632.10 | 0.56 | 2730.00 | 1466.95 | 69869.09 |
| Cipla | 710.55 | -1.35 | 734.00 | 356.75 | 57291.64 |
| Aurobindo Pharma | 867.65 | -0.79 | 886.90 | 281.15 | 50835.61 |
| Biocon | 411.60 | 0.48 | 455.00 | 211.30 | 49392.00 |
| Torrent Pharma. | 2731.00 | 2.57 | 2772.10 | 1554.65 | 46213.98 |
| Lupin | 927.00 | 0.03 | 955.85 | 505.00 | 42007.00 |
| Cadila Health. | 395.15 | 1.72 | 400.70 | 206.45 | 40451.51 |
| Abbott India | 15996.95 | 2.95 | 18569.00 | 8336.30 | 33993.52 |
| Alkem Lab | 2794.25 | 4.95 | 2882.10 | 1662.30 | 33405.26 |
| Piramal Enterp. | 1460.15 | -1.01 | 2001.24 | 608.00 | 32933.68 |
| Glaxosmi. Pharma | 1478.65 | 2.84 | 1745.00 | 1046.40 | 25049.81 |
| Ipca Labs. | 1887.95 | 0.22 | 2032.90 | 844.20 | 23854.25 |
| Apollo Hospitals | 1574.00 | -6.05 | 1814.00 | 1047.45 | 21897.49 |
| Pfizer | 4397.65 | 2.95 | 5172.95 | 2797.50 | 20119.25 |
| Sanofi India | 8306.40 | 6.86 | 8528.45 | 5610.00 | 19129.64 |
| Syngene Intl. | 478.00 | -1.84 | 504.20 | 201.65 | 19120.00 |
| Alembic Pharma | 989.35 | 0.41 | 1044.25 | 436.10 | 18649.25 |
| Dr Lal Pathlabs | 1862.45 | -1.40 | 2029.85 | 1052.55 | 15521.66 |
Quick Links for Parnax Lab:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
